Key facts
- This page summarizes Eugene Frederick Leffler III's Form 4 filing for Biofrontera Inc. (BFRI).
- 4 reported transactions and 3 derivative rows are listed below.
- Filing timestamp: 16 Sep 2025, 21:19.
Eugene Frederick Leffler III - 22 Jul 2025 Form 4 Insider Report for Biofrontera Inc. (BFRI)
- Signature
- /s/ Daniel Hakansson, Attorney-in-fact for Eugene Frederick Leffler III
- Issuer symbol
- BFRI
- Transactions as of
- 22 Jul 2025
- Net transaction value
- $0
- Form type
- 4
- Filing time
- 16 Sep 2025, 21:19:41 UTC
- Previous filing
- 16 Jul 2024
- Next filing
- 06 Mar 2026
- SEC filing
- View on sec.gov
Reporting owner
Issuer context
Transaction snapshot
SEC evidence
Key filing fact
Eugene Frederick Leffler III filed Form 4 for Biofrontera Inc. (BFRI) on 16 Sep 2025.
Change
- Previous filing in this sequence was filed on 16 Jul 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001952347
Primary reporting owner
Leffler Eugene Frederick
- Relationship
- Chief Financial Officer
- Address
- 120 PRESIDENTIAL WAY, SUITE 330, WOBURN
- Signature
- /s/ Daniel Hakansson, Attorney-in-fact for Eugene Frederick Leffler III
- Signature date
- 16 Sep 2025
Reported transactions
BFRI
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +87,500
- Change %
- Price
- Shares after
- 87,500
- Date
- 10 Sep 2025
- Ownership
- Direct
- Footnotes
- F1
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
BFRI
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +62,500
- Change %
- Price
- $0.000000
- Shares after
- 62,500
- Date
- 22 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 62,500
- Exercise price
- Footnotes
- F2, F3, F6
BFRI
transaction
Derivative
Employee stock option (right to buy)
Award
- Transaction value
- $0
- Shares
- +62,500
- Change %
- Price
- $0.000000
- Shares after
- 62,500
- Date
- 22 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 62,500
- Exercise price
- $1.00
- Footnotes
- F4, F7
BFRI
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -87,500
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 87,500
- Date
- 10 Sep 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 87,500
- Exercise price
- Footnotes
- F1, F5, F6
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Restricted stock units convert into common stock on a one-for-one basis. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of BFRI common stock. The reporting person received the restricted stock units as an award for no consideration. |
| F3 | The restricted stock units vest in two equal yearly installments for the first two years following the grant date, beginning on July 22, 2026. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date. |
| F4 | The option vests in two equal annual installments beginning on January 22, 2026. |
| F5 | On July 12, 2024 the reporting person was granted 175,000 restricted stock units, vesting in two equal annual installments beginning on July 12, 2025. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date. |
| F6 | Restricted stock units with different terms are not included. |
| F7 | Options with different terms are not included |